Susanna Campesan

895 total citations
18 papers, 705 citations indexed

About

Susanna Campesan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cell Biology. According to data from OpenAlex, Susanna Campesan has authored 18 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Susanna Campesan's work include Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (9 papers) and Tryptophan and brain disorders (4 papers). Susanna Campesan is often cited by papers focused on Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (9 papers) and Tryptophan and brain disorders (4 papers). Susanna Campesan collaborates with scholars based in United Kingdom, United States and Germany. Susanna Campesan's co-authors include Flaviano Giorgini, Charalambos P. Kyriacou, Edward W. Green, Carlo Breda, Paul J. Muchowski, Robert Schwarcz, Korrapati V. Sathyasaikumar, Paul Richards, Nicola Butler and Robert P. Mason and has published in prestigious journals such as Nature Genetics, Current Biology and Genetics.

In The Last Decade

Susanna Campesan

18 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanna Campesan United Kingdom 13 373 283 152 116 108 18 705
Carlo Breda United Kingdom 15 395 1.1× 371 1.3× 283 1.9× 197 1.7× 120 1.1× 22 1.1k
Daniel C. Maddison United Kingdom 9 247 0.7× 81 0.3× 219 1.4× 72 0.6× 81 0.8× 16 580
Nay L. Saw United States 10 381 1.0× 216 0.8× 55 0.4× 72 0.6× 35 0.3× 15 733
Giulia Albertini Belgium 15 195 0.5× 242 0.9× 86 0.6× 77 0.7× 24 0.2× 28 598
Geneviève Beauvais United States 12 284 0.8× 336 1.2× 42 0.3× 141 1.2× 72 0.7× 17 632
А. P. Bolshakov Russia 14 368 1.0× 243 0.9× 40 0.3× 34 0.3× 52 0.5× 50 641
Zhenzhen Quan China 17 414 1.1× 148 0.5× 60 0.4× 68 0.6× 36 0.3× 47 828
Étienne Hébert-Chatelain Canada 17 447 1.2× 212 0.7× 38 0.3× 52 0.4× 55 0.5× 31 896
László Havas Hungary 11 137 0.4× 173 0.6× 188 1.2× 146 1.3× 18 0.2× 20 646
Péter Gulyássy Hungary 13 233 0.6× 176 0.6× 71 0.5× 24 0.2× 55 0.5× 15 563

Countries citing papers authored by Susanna Campesan

Since Specialization
Citations

This map shows the geographic impact of Susanna Campesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanna Campesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanna Campesan more than expected).

Fields of papers citing papers by Susanna Campesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanna Campesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanna Campesan. The network helps show where Susanna Campesan may publish in the future.

Co-authorship network of co-authors of Susanna Campesan

This figure shows the co-authorship network connecting the top 25 collaborators of Susanna Campesan. A scholar is included among the top collaborators of Susanna Campesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanna Campesan. Susanna Campesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tufi, Roberta, et al.. (2024). Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models. Cell Reports. 43(2). 113681–113681. 11 indexed citations
2.
Campesan, Susanna, Anna Straatman-Iwanowska, Mariaelena Repici, et al.. (2023). Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila. Neurobiology of Disease. 185. 106236–106236. 8 indexed citations
3.
Delfino, Laura, Susanna Campesan, Giorgio Fedele, et al.. (2022). Visualization of Mutant Aggregates from Clock Neurons by Agarose Gel Electrophoresis (AGERA) in Drosophila melanogaster. Methods in molecular biology. 2482. 373–383. 2 indexed citations
4.
Koss, David J., Susanna Campesan, Flaviano Giorgini, & Tiago F. Outeiro. (2021). Dysfunction of RAB39B‐Mediated Vesicular Trafficking in Lewy Body Diseases. Movement Disorders. 36(8). 1744–1758. 13 indexed citations
5.
Maddison, Daniel C., Carlo Breda, Susanna Campesan, et al.. (2020). A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics. PLoS Genetics. 16(11). e1009129–e1009129. 15 indexed citations
6.
Naia, Luana, Catarina Carmo, Susanna Campesan, et al.. (2020). Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics. Free Radical Biology and Medicine. 163. 163–179. 60 indexed citations
7.
Robinson, Susan W., Julie-Myrtille Bourgognon, Jereme G. Spiers, et al.. (2018). Nitric oxide-mediated posttranslational modifications control neurotransmitter release by modulating complexin farnesylation and enhancing its clamping ability. PLoS Biology. 16(4). e2003611–e2003611. 31 indexed citations
8.
Naia, Luana, Catarina Carmo, Susanna Campesan, et al.. (2018). SIRT3, a modifier of mitochondrial function in Huntington's disease. Free Radical Biology and Medicine. 120. S17–S17. 1 indexed citations
9.
Green, Edward W., Leonor Miller‐Fleming, Sarah Hands, et al.. (2013). DJ-1 modulates aggregation and pathogenesis in models of Huntington's disease. Human Molecular Genetics. 23(3). 755–766. 39 indexed citations
10.
Mason, Robert P., Nicola Butler, Carlo Breda, et al.. (2013). Glutathione peroxidase activity is neuroprotective in models of Huntington's disease. Nature Genetics. 45(10). 1249–1254. 115 indexed citations
11.
Green, Edward W., Susanna Campesan, Carlo Breda, et al.. (2012). Drosophila eye color mutants as therapeutic tools for Huntington disease. Fly. 6(2). 117–120. 30 indexed citations
12.
Steinert, Joern R., Susanna Campesan, Paul Richards, et al.. (2012). Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease. Human Molecular Genetics. 21(13). 2912–2922. 58 indexed citations
13.
Campesan, Susanna, Edward W. Green, Carlo Breda, et al.. (2011). The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease. Current Biology. 21(11). 961–966. 198 indexed citations
14.
Richards, Paul, Claire Didszun, Susanna Campesan, et al.. (2010). Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease. Cell Death and Differentiation. 18(2). 191–200. 66 indexed citations
15.
Campesan, Susanna, et al.. (2002). Nucleotide variation at the no-on-transient A gene in Drosophila littoralis. Heredity. 88(1). 39–45. 4 indexed citations
16.
Sandrelli, Federica, Susanna Campesan, Clara Benna, et al.. (2001). Molecular Dissection of the 5′ Region ofno-on-transientAofDrosophila melanogasterRevealscis-Regulation by AdjacentdGpi1Sequences. Genetics. 157(2). 765–775. 14 indexed citations
17.
Campesan, Susanna, David Chalmers, Federica Sandrelli, et al.. (2001). Comparative Analysis of the nonA Region in Drosophila Identifies a Highly Diverged 5′ Gene That May Constrain nonA Promoter Evolution. Genetics. 157(2). 751–764. 13 indexed citations
18.
Campesan, Susanna, Yuri E. Dubrova, Jeffrey C. Hall, & Charalambos P. Kyriacou. (2001). The nonA Gene in Drosophila Conveys Species-Specific Behavioral Characteristics. Genetics. 158(4). 1535–1543. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026